Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated November 2nd, 2020

Imbruvica Treats Relapsed Lymphoma in a Different Way

×
NOW
PLAYING
Fox Reporter and Blood Cancer Survivor Amanda Salas Is Encouraging Others to Trade in Beauty Standards for Health this Summer
NOW
PLAYING
FDA Approves First Targeted Therapy For Lung Cancer Patients With the KRAS Gene Mutation
NOW
PLAYING
'An Important Step Forward': New Drug Combo Shows Promise For The Treatment Of Some Ovarian Cancer
NOW
PLAYING
Remembering Stylish First Lady Jackie Kennedy, Who Passed Away 27 Years Ago From Non-Hodgkin Lymphoma
NOW
PLAYING
Treating Chronic Lymphocytic Leukemia With BTK Inhibitors
NOW
PLAYING
FOX Anchor Lindy Thackston Shares Story of Ending her Chemo Early

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

SEE MORE   

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

  • There are several treatment options available if non-Hodgkin lymphoma returns
  • The most common first treatment after relapse is another round of chemotherapy
  • For patients whose cancer does not respond well to chemo, doctors may explore immune-therapies such as CAR-T therapy
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.